We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Parexel International Corp. | NASDAQ:PRXL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 88.08 | 88.10 | 88.11 | 0 | 01:00:00 |
PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.
A live webcast of the presentation will be available through the “Investors” section of PAREXEL’s website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website for 90 days after the presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 82 locations in 51 countries around the world, and had approximately 18,450 employees in the third quarter. For more information about PAREXEL International, visit www.PAREXEL.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160524005121/en/
PAREXEL InternationalRonald Aldridge, + 1-781-434-4753Senior Director of Investor RelationsRon.Aldridge@PAREXEL.com
1 Year Parexel Chart |
1 Month Parexel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions